Earnings call transcript: Iterum Therapeutics reports Q4 2024 results and stock surges
Iterum Therapeutics PLC (NASDAQ:ITRM) reported its fourth-quarter 2024 financial results, revealing a narrower-than-expected loss. The company posted an actual EPS of -0.12, beating the forecasted EPS ...
Earnings call transcript: Carlisle's Q4 2024 EPS beats forecast, stock dips
Carlisle Companies Incorporated reported its Q4 2024 earnings, with adjusted earnings per share (EPS) surpassing expectations. The company's revenue fell short of forecasts, leading to a notable drop ...